Prot# MANON 02: A Phase II, Randomized, Placebo-Controlled Study to Evaluate the Immunogenicity and the Safety of Two Schedules of an Homologous Prime-Boost with the ALVAC-HIV vCP1452 in Chronically HIV-Infected Patients